Applications Covered by Section 505(b)(2)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 8, 1999
February 1, 2021
5f0df47f-0a4f-498e-9b76-34682f4067f5
Related Documents
Establishing Impurity Specifications for Antibiotics
Guidance DocumentApril 20, 2026Center for Drug Evaluation and Research
Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action
Guidance DocumentApril 3, 2003Center for Drug Evaluation and Research
How to Comply with the Pediatric Research Equity Act
Guidance DocumentSeptember 7, 2005Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.